Clinical Trial Update: Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating infigratinib in patients with locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma has been term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• Infigratinib (infigratinib)

Snippet

Sponsor: LianBio LLC | Conditions: Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | Phase 2 | Status: TERMINATED